User menu

Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.

Bibliographic reference Damien, Gheldof ; Hélène, Haguet ; Jean-Michel, Dogné ; Céline, Bouvy ; Graux, Carlos ; et. al. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.. In: Journal of Thrombosis and Thrombolysis : an international journal for clinicians and scientists, Vol. 43, no. 2, p. 224-232 (2017)
Permanent URL
  1. Ku G. H., White R. H., Chew H. K., Harvey D. J., Zhou H., Wun T., Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival, 10.1182/blood-2008-08-175745
  2. Kwaan Hau, Magalhães Rego Eduardo, Role of Microparticles in the Hemostatic Dysfunction in Acute Promyelocytic Leukemia, 10.1055/s-0030-1267045
  3. Khorana Alok A., Venous Thromboembolism Prevention in Cancer Outpatients, 10.6004/jnccn.2013.0164
  4. Khorana Alok A., Dalal Mehul, Lin Jay, Connolly Gregory C., Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States : VTE in Ambulatory US Cancer Patients, 10.1002/cncr.27772
  5. DAVILA M., AMIRKHOSRAVI A., COLL E., DESAI H., ROBLES L., COLON J., BAKER C. H., FRANCIS J. L., Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation, 10.1111/j.1538-7836.2008.02987.x
  6. TESSELAAR M. E. T., ROMIJN F. P. H. T. M., VAN DER LINDEN I. K., PRINS F. A., BERTINA R. M., OSANTO S., Microparticle-associated tissue factor activity: a link between cancer and thrombosis?, 10.1111/j.1538-7836.2007.02369.x
  7. Pollyea Daniel A., Kohrt Holbrook E., Medeiros Bruno C., Acute myeloid leukaemia in the elderly: a review : Review, 10.1111/j.1365-2141.2010.08470.x
  8. Schneider Pascale, Dreden Patrick Van, Rousseau Aurélie, Kassim Yusra, Legrand Elisabeth, Vannier Jean-Pierre, Vasse Marc, Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia, 10.1111/j.1365-2141.2009.07958.x
  9. Gheldof Damien, Mullier François, Bailly Nicolas, Devalet Bérangère, Dogné Jean-Michel, Chatelain Bernard, Chatelain Christian, Microparticle bearing tissue factor: A link between promyelocytic cells and hypercoagulable state, 10.1016/j.thromres.2013.11.008
  10. Furie Bruce, Furie Barbara C., Mechanisms of Thrombus Formation, 10.1056/nejmra0801082
  11. Mackman N., Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development, 10.1161/01.atv.0000130465.23430.74
  12. ZHOU J., SHI J., HOU J., CAO F., ZHANG Y., RASMUSSEN J. T., HEEGAARD C. W., GILBERT G. E., Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia, 10.1111/j.1538-7836.2010.03763.x
  13. Thaler Johannes, Pabinger Ingrid, Sperr Wolfgang R., Ay Cihan, Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia, 10.1016/j.thromres.2013.12.029
  14. Issman Liron, Brenner Benjamin, Talmon Yeshayahu, Aharon Anat, Cryogenic Transmission Electron Microscopy Nanostructural Study of Shed Microparticles, 10.1371/journal.pone.0083680
  15. Waisman Dan, Danino Dganit, Weintraub Zalman, Schmidt Judith, Talmon Yeshayahu, Nanostructure of the aqueous form of lung surfactant of different species visualized by cryo-transmission electron microscopy, 10.1111/j.1475-097x.2007.00763.x
  16. Tatischeff Irène, Larquet Eric, Falcón-Pérez Juan M., Turpin Pierre-Yves, Kruglik Sergei G., Fast characterisation of cell-derived extracellular vesicles by nanoparticles tracking analysis, cryo-electron microscopy, and Raman tweezers microspectroscopy, 10.3402/jev.v1i0.19179
  17. Gheldof Damien, Hardij Julie, Cecchet Francesca, Chatelain Bernard, Dogné Jean-Michel, Mullier François, Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles, 10.3402/jev.v2i0.19728
  18. Gheldof Damien, Mullier François, Chatelain Bernard, Dogné Jean-Michel, Chatelain Christian, Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles : , 10.1097/mbc.0b013e328360a56e
  19. Walter R. B., Othus M., Burnett A. K., Lowenberg B., Kantarjian H. M., Ossenkoppele G. J., Hills R. K., van Montfort K. G. M., Ravandi F., Evans A., Pierce S. R., Appelbaum F. R., Estey E. H., Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients, 10.1182/blood-2012-10-462440
  20. Carrier M., Khorana A. A., Zwicker J. I., Noble S., Lee A. Y. Y., , Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a reply to a rebuttal, 10.1111/jth.12444
  21. Kaatz S., Ahmad D., Spyropoulos A. C., Schulman S., , Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH, 10.1111/jth.13140
  22. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330
  23. Knöbl Paul N., On the Evaluation of the ISTH Score for Overt Disseminated Intravascular Coagulation : , 10.1097/01.ccm.0000163228.76094.44
  24. Schultz Kirk R., Massing Bonnie, Spinelli John J., Gaynon Paul S., Wadsworth Louis, Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia, 10.1002/(sici)1096-911x(199707)29:1<16::aid-mpo3>;2-v
  25. Robert Séverine, Ghiotto Jérémie, Pirotte Bernard, David Jean-Louis, Masereel Bernard, Pochet Lionel, Dogné Jean-Michel, Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?, 10.1016/j.phrs.2008.12.003
  26. Mullier F., Bailly N., Chatelain C., Chatelain B., Dogné J.-M., Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions, 10.1111/jth.12171
  27. Hemker H.C., Giesen P., AlDieri R., Regnault V., de Smed E., Wagenvoord R., Lecompte T., Béguin S., The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability, 10.1159/000073575
  28. Khorana Alok A., Connolly Gregory C., Assessing Risk of Venous Thromboembolism in the Patient With Cancer, 10.1200/jco.2009.22.3271
  29. Owens AP 3rd, Mackman N (2012) Microparticles in hemostasis and thrombosis. Circ Res 108:1284–1297
  30. Lima L. G., Oliveira A. S., Campos L. C., Bonamino M., Chammas R., Werneck C., Vicente C. P., Barcinski M. A., Petersen L. C., Monteiro R. Q., Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles : , 10.1160/th11-03-0143
  31. Li M., Yu D., Williams K. J., Liu M.-L., Tobacco Smoke Induces the Generation of Procoagulant Microvesicles From Human Monocytes/Macrophages, 10.1161/atvbaha.110.209577
  32. VAN AALDEREN M. C., TRAPPENBURG M. C., VAN SCHILFGAARDE M., MOLENAAR P. J., TEN CATE H., TERPSTRA W. E., LEYTE A., Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy : Letters to the Editor, 10.1111/j.1538-7836.2010.04133.x
  33. Langer F, Amirkhosravi A, Loges S, Meyer T, Eifrig B, Hossfeld DK, Fiedler W, Francis JL (2004) An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF. Thromb Haemost 92:1136–1146
  34. Langer F., Ruf W., Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation : , 10.1160/th13-09-0802
  35. Tormoen Garth W, Recht Olivia, Gruber András, Levine Ross L, McCarty Owen J T, Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells, 10.1088/1478-3975/10/5/056010
  36. Marchetti Marina, Russo Laura, Balducci Donatella, Falanga Anna, All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells, 10.1016/j.thromres.2011.03.006
  37. Zhang XH, Hu Y, Hong M, Xia LH, Guo T, Shen GX, Wei WN, Song SJ (2007) Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells. J Exp Hematol Chin Assoc Pathophysiol 15:391–395
  38. Hellum Marit, Øvstebø Reidun, Trøseid Anne-Marie S., Berg Jens P., Brandtzaeg Petter, Henriksson Carola E., Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay : , 10.1097/mbc.0b013e328354a256
  39. Tatsumi K., Antoniak S., Monroe D. M., Khorana A. A., Mackman N., , Evaluation of a new commercial assay to measure microparticle tissue factor activity in plasma: communication from the SSC of the ISTH, 10.1111/jth.12718
  40. Gheldof Damien, Chatelain Christian, Dogné Jean-Michel, Mullier François, Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia, 10.1016/j.thromres.2014.05.001